Castle Biosciences (CSTL) Cash from Investing Activities Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) Cash from Investing Activities Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -188.86% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 2.46% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | 13.86% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | -59.07% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -48.84% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 64.36% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 41.86% |
| 10 | Castle Biosciences | 917.75 Mn | 650.93 Mn | 79.85 Mn | -1.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.23% |
| Mar 31, 2026 | -52.63% |
| Dec 31, 2025 | 58.35% |
| Sep 30, 2025 | 48.44% |
| Jun 30, 2025 | -1.04% |
| Mar 31, 2025 | -282.13% |
| Dec 31, 2024 | 29.80% |
| Sep 30, 2024 | -152.10% |
| Jun 30, 2024 | 14.36% |
| Mar 31, 2024 | -197.26% |
| Dec 31, 2023 | -135.42% |
| Sep 30, 2023 | -72.12% |
| Jun 30, 2023 | -106.16% |
| Mar 31, 2023 | 227.63% |
| Dec 31, 2022 | -134.63% |
| Sep 30, 2022 | -831.45% |
| Jun 30, 2022 | -434.66% |
| Mar 31, 2022 | -18.11% |
| Dec 31, 2021 | -1,690.64% |
| Sep 30, 2021 | -119.72% |